Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 20, 1990 - Issue 4
Submit an article Journal homepage
7
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboon

D. McKillop Drug Kinetics Group, Safety of Medicines Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
,
K. J. Pickup Drug Kinetics Group, Safety of Medicines Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
,
A. J. Swaisland Drug Kinetics Group, Safety of Medicines Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
&
B. F. Holmes Drug Kinetics Group, Safety of Medicines Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
Pages 401-415 | Received 27 Jun 1989, Accepted 01 Dec 1989, Published online: 22 Sep 2008

References

  • Arbogast R., Brandt C. M., Fincker J. L., Schechter P. J. Acute haemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside. Journal of Cardiovascular Pharmacology 1986; 8: 82–89
  • Baim D. S., McDowell A. V., Cherniles J., Monrad E. S., Parker J. A., Edelson J., Braunwald E., Grossman W. Evaluation of a new bipyridine inotropic agent- milrinone-in patients with severe congestive heart failure. New England Journal of Medicine 1983; 309: 748–756
  • Baker J. F., Chalecki B. W., Benziger D. P., O'Melia P. E., Clemans S. D., Edelson J. Metabolism of amrinone in animals. Drug Metabolism and Disposition 1982; 10: 168–172
  • Boyd R. M. Evidence for the Clara cell as a site for cytochrome P450-dependent mixed-function oxidase activity in the lung. Nature 1977; 269: 713–715
  • Brittebo E. B., Åhlman M. Metabolism of a nasal carcinogen, phenacetin, in the mucosa of the upper respiratory tract. Chemico-Biological Interactions 1984; 50: 233–245
  • Caldwell J. Conjugation reactions in foreign-compound metabolism: definition, consequences and species variations. Drug Metabolism Reviews 1982; 13: 745–777
  • Case D. E. Incorporation into endogenous metabolic pathways of small fragments derived from ICI 58,834 (Viloxazine). Xenobiotica 1975; 5: 133–143
  • Chaudhuri N. K., Servando O. A., Manniello M. J., Luders R. C., Chao D. K., Bartlett M. F. Metabolism of tripelennamine in man. Drug Metabolism and Disposition 1976; 4: 372–378
  • Collis M. G., Keddie J. R., Rouse W. The cardiovascular pharmacology of ICI 170,777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4-thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects. British Journal of Pharmacology 1989; 97: 409–418
  • Dahl A. R. Activation of carcinogens and other xenobiotics by nasal cytochromes P450. Microsomes and Drug Oxidations, A. R. Boobis, J. Caldwell, F. DeMatteis, C. R. Elcombe. Taylor & Francis, London 1985; 299–309
  • Damani L. A., Crooks P. A., Shaker M. S., Caldwell J., D'Souza J., Smith R. L. Species differences in the metabolic C- and N-oxidation, and N-methylation of [14C]pyridine in vivo. Xenobiotica 1982; 12: 527–534
  • Fischer L. J., Thies R. L., Charkowski D., Donham K. J. Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees and humans. Drug Metabolism and Disposition 1980; 8: 422–424
  • Hucker H. B., Stauffer S. C., Balletto A. J., White S. D., Zacchel A. G., Arison B. H. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, Rhesus monkey and man. Drug Metabolism and Disposition 1978; 6: 659–672
  • Löfberg B., Brittebo E. B., Tjälve H. Localization and binding of N'-nitrosonornicotine metabolites in the nasal region and in some other tissues of Sprague-Dawley rats. Cancer Research 1982; 42: 2877–2883
  • Reed C. J., Lock E. A., DeMatteis F. NADPH:cytochrome P450 reductase in olfactory epithelium. Biochemical Journal 1986; 240: 585–592
  • Weber K. T., Andrews V., Janicki J. S., Wilson J. R., Fishman A. P. Amrinone and exercise performance in patients with chronic heart failure. American Journal of Cardiology 1981; 48: 164–169

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.